Back to User profile » Dr Yilan Wu
Paper published by Dr Yilan Wu:
Original Research
Insight into resistance mechanism of anaplastic lymphoma kinase to alectinib and JH-VIII-157-02 caused by G1202R solvent front mutation
Wang H, Wang Y, Guo W, Du B, Huang X, Wu R, Yang B, Lin X, Wu Y
Drug Design, Development and Therapy 2018, 12:1183-1193
Published Date: 9 May 2018